Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 846

1.

Hypogonadism and prostate cancer detection on multiparametric MRI and mpMRI-TRUS fusion biopsy.

Sugano D, Sidana A, Jain AL, Calio B, Gaur S, Maruf M, Merino M, Choyke P, Turkbey B, Wood BJ, Pinto PA.

Int Urol Nephrol. 2019 Dec 5. doi: 10.1007/s11255-019-02354-4. [Epub ahead of print]

PMID:
31807974
2.

18F-fluciclovine PET or PSMA PET for prostate cancer imaging?

Turkbey B, Choyke PL.

Nat Rev Urol. 2019 Nov 1. doi: 10.1038/s41585-019-0255-6. [Epub ahead of print] No abstract available.

PMID:
31676885
3.

18F-DCFPyL PET/CT Imaging in Patients with Biochemical Recurrence Prostate Cancer after Primary Local Therapy.

Mena E, Lindenberg ML, Turkbey IB, Shih JH, Harmon SA, Lim I, Lin FI, Adler S, Eclarinal P, McKinney Y, Citrin D, Dahut W, Wood B, Krishnasamy V, Chang R, Levy E, Merino M, Pinto P, Eary JF, Choyke PL.

J Nucl Med. 2019 Nov 1. pii: jnumed.119.234799. doi: 10.2967/jnumed.119.234799. [Epub ahead of print]

PMID:
31676732
4.

Ferumoxytol-Enhanced MR Lymphography for Detection of Metastatic Lymph Nodes in Genitourinary Malignancies: A Prospective Study.

Turkbey B, Czarniecki M, Shih JH, Harmon SA, Agarwal PK, Apolo AB, Citrin DE, Gulley JL, Harisinghani M, Madan RA, Metwalli AR, Paquette E, Pinto PA, Rais-Bahrami S, Rowe LS, Wood BJ, Jacobs PM, Lindenberg L, Dahut W, Choyke PL.

AJR Am J Roentgenol. 2019 Oct 15:1-9. doi: 10.2214/AJR.19.21264. [Epub ahead of print]

PMID:
31613660
5.

Erratum: Prostate cancer detection from multi-institution multiparametric MRIs using deep convolutional neural networks system (Erratum).

Sumathipala Y, Lay N, Turkbey B, Smith C, Choyke PL, Summers RM.

J Med Imaging (Bellingham). 2019 Jul;6(3):039803. doi: 10.1117/1.JMI.6.3.039803. Epub 2019 Sep 27.

6.

Prostate specific membrane antigen (PSMA) imaging: the past is prologue.

Choyke PL, Bouchelouche K.

Transl Androl Urol. 2019 Aug;8(4):283-285. doi: 10.21037/tau.2019.07.20. No abstract available.

7.

Near-infrared photoimmunotherapy through bone.

Nakamura YA, Okuyama S, Furusawa A, Nagaya T, Fujimura D, Okada R, Maruoka Y, Eclarinal PC, Choyke PL, Kobayashi H.

Cancer Sci. 2019 Dec;110(12):3689-3694. doi: 10.1111/cas.14203. Epub 2019 Oct 22.

8.

18F-Sodium fluoride PET/CT predicts overall survival in patients with advanced genitourinary malignancies treated with cabozantinib and nivolumab with or without ipilimumab.

Lim I, Lindenberg ML, Mena E, Verdini N, Shih JH, Mayfield C, Thompson R, Lin J, Vega A, Mallek M, Cadena J, Diaz C, Mortazavi A, Knopp M, Wright C, Stein M, Pal S, Choyke PL, Apolo AB.

Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):178-184. doi: 10.1007/s00259-019-04483-5. Epub 2019 Sep 14.

PMID:
31522271
9.

A STUDY OF 219Rn OUTGASSING AND 211Pb CONTAMINATION FROM 223Ra IN DRY, LIQUID, AND MURINE TISSUE SAMPLES.

Adler S, Baidoo K, Jagoda E, Phelps T, Roy J, Seidel J, Lin F, Choyke P.

Health Phys. 2019 Oct 7. doi: 10.1097/HP.0000000000001132. [Epub ahead of print]

PMID:
31517652
10.

A multiparametric magnetic resonance imaging-based virtual reality surgical navigation tool for robotic-assisted radical prostatectomy.

Mehralivand S, Kolagunda A, Hammerich K, Sabarwal V, Harmon S, Sanford T, Gold S, Hale G, Romero VV, Bloom J, Merino MJ, Wood BJ, Kambhamettu C, Choyke PL, Pinto PA, Türkbey B.

Turk J Urol. 2019 Sep 1;45(5):357-365. doi: 10.5152/tud.2019.19133.

11.

The Effect of Antibody Fragments on CD25 Targeted Regulatory T Cell Near-Infrared Photoimmunotherapy.

Okada R, Maruoka Y, Furusawa A, Inagaki F, Nagaya T, Fujimura D, Choyke PL, Kobayashi H.

Bioconjug Chem. 2019 Oct 16;30(10):2624-2633. doi: 10.1021/acs.bioconjchem.9b00547. Epub 2019 Sep 23.

PMID:
31498995
12.

Near-Infrared Photoimmunotherapy: Photoactivatable Antibody-Drug Conjugates (ADCs).

Kobayashi H, Griffiths GL, Choyke PL.

Bioconjug Chem. 2019 Sep 13. doi: 10.1021/acs.bioconjchem.9b00546. [Epub ahead of print]

PMID:
31479610
13.

Apical periurethral transition zone lesions: MRI and histology findings.

Tuncer S, Mehralivand S, Harmon SA, Sanford T, Brown GT, Rowe LS, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

Abdom Radiol (NY). 2019 Aug 29. doi: 10.1007/s00261-019-02194-x. [Epub ahead of print]

PMID:
31468153
14.

In Vitro Performance of Published Glypican 3-Targeting Peptides TJ12P1 and L5 Indicates Lack of Specificity and Potency.

Berman RM, Kelada OJ, Gutsche NT, Natarajan R, Swenson RE, Fu Y, Hong J, Ho M, Choyke PL, Escorcia FE.

Cancer Biother Radiopharm. 2019 Oct;34(8):498-503. doi: 10.1089/cbr.2019.2888. Epub 2019 Aug 19.

15.

Imaging of glucose metabolism by 13C-MRI distinguishes pancreatic cancer subtypes in mice.

Kishimoto S, Brender JR, Crooks DR, Matsumoto S, Seki T, Oshima N, Merkle H, Lin P, Reed G, Chen AP, Ardenkjaer-Larsen JH, Munasinghe J, Saito K, Yamamoto K, Choyke PL, Mitchell J, Lane AN, Fan TW, Linehan WM, Krishna MC.

Elife. 2019 Aug 13;8. pii: e46312. doi: 10.7554/eLife.46312.

16.

Editorial: assessment of 68Ga-PSMA-11 PET accuracy in localizing recurrent prostate cancer, a prospective single arm clinical study: California shows the way!

Choyke P.

Transl Androl Urol. 2019 Jul;8(Suppl 3):S296-S299. doi: 10.21037/tau.2019.06.11. No abstract available.

17.

Near-Infrared Photoimmunotherapy of Cancer.

Kobayashi H, Choyke PL.

Acc Chem Res. 2019 Aug 20;52(8):2332-2339. doi: 10.1021/acs.accounts.9b00273. Epub 2019 Jul 23.

18.

Lymph node involvement in treatment-naïve prostate cancer patients - correlation of PSMA-PET/CT imaging and Roach formula in 280 men in the Radiotherapeutic management.

Koerber SA, Stach G, Kratochwil C, Haefner MF, Rathke H, Herfarth K, Kopka K, Holland-Letz T, Choyke PL, Will L, Haberkorn U, Debus J, Giesel FL.

J Nucl Med. 2019 Jul 13. pii: jnumed.119.227637. doi: 10.2967/jnumed.119.227637. [Epub ahead of print]

PMID:
31302638
19.

Fluorine-18 Labeled Fluorofuranylnorprogesterone ([18F]FFNP) and Dihydrotestosterone ([18F]FDHT) Prepared by "Fluorination on Sep-Pak" Method.

Basuli F, Zhang X, Blackman B, White ME, Jagoda EM, Choyke PL, Swenson RE.

Molecules. 2019 Jun 28;24(13). pii: E2389. doi: 10.3390/molecules24132389.

20.

High-fidelity detection and sorting of nanoscale vesicles in viral disease and cancer.

Morales-Kastresana A, Musich TA, Welsh JA, Telford W, Demberg T, Wood JCS, Bigos M, Ross CD, Kachynski A, Dean A, Felton EJ, Van Dyke J, Tigges J, Toxavidis V, Parks DR, Overton WR, Kesarwala AH, Freeman GJ, Rosner A, Perfetto SP, Pasquet L, Terabe M, McKinnon K, Kapoor V, Trepel JB, Puri A, Kobayashi H, Yung B, Chen X, Guion P, Choyke P, Knox SJ, Ghiran I, Robert-Guroff M, Berzofsky JA, Jones JC.

J Extracell Vesicles. 2019 Jun 19;8(1):1597603. doi: 10.1080/20013078.2019.1597603. eCollection 2019.

21.

PI-RADS version 2.1: one small step for prostate MRI.

Barrett T, Rajesh A, Rosenkrantz AB, Choyke PL, Turkbey B.

Clin Radiol. 2019 Nov;74(11):841-852. doi: 10.1016/j.crad.2019.05.019. Epub 2019 Jun 22. Review.

PMID:
31239107
22.

New Targets for PET Molecular Imaging of Prostate Cancer.

Mena E, Lindenberg LM, Choyke PL.

Semin Nucl Med. 2019 Jul;49(4):326-336. doi: 10.1053/j.semnuclmed.2019.02.001. Epub 2019 Mar 9. Review.

PMID:
31227055
23.

Impact of Anatomic Location of Bone Metastases on Prognosis in Metastatic Castration-Resistant Prostate Cancer.

Roth AR, Harmon SA, Perk TG, Eickhoff J, Choyke PL, Kurdziel KA, Dahut WL, Apolo AB, Morris MJ, Perlman SB, Liu G, Jeraj R.

Clin Genitourin Cancer. 2019 Aug;17(4):306-314. doi: 10.1016/j.clgc.2019.05.013. Epub 2019 May 27.

PMID:
31221545
24.

Fully automated prostate whole gland and central gland segmentation on MRI using holistically nested networks with short connections.

Cheng R, Lay N, Roth HR, Turkbey B, Jin D, Gandler W, McCreedy ES, Pohida T, Pinto P, Choyke P, McAuliffe MJ, Summers RM.

J Med Imaging (Bellingham). 2019 Apr;6(2):024007. doi: 10.1117/1.JMI.6.2.024007. Epub 2019 Jun 5.

PMID:
31205977
25.

Use of multiparametric magnetic resonance imaging and fusion-guided biopsies to properly select and follow African-American men on active surveillance.

Bloom JB, Lebastchi AH, Gold SA, Hale GR, Sanford T, Mehralivand S, Ahdoot M, Rayn KN, Czarniecki M, Smith C, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

BJU Int. 2019 Nov;124(5):768-774. doi: 10.1111/bju.14835. Epub 2019 Jun 26.

PMID:
31141307
26.

Index tumor volume on MRI as a predictor of clinical and pathologic outcomes following radical prostatectomy.

Sugano D, Sidana A, Jain AL, Calio B, Gaur S, Maruf M, Merino M, Choyke P, Turkbey B, Wood BJ, Pinto PA.

Int Urol Nephrol. 2019 Aug;51(8):1349-1355. doi: 10.1007/s11255-019-02168-4. Epub 2019 May 16.

PMID:
31098818
27.

Artificial intelligence at the intersection of pathology and radiology in prostate cancer.

Harmon SA, Tuncer S, Sanford T, Choyke PL, Türkbey B.

Diagn Interv Radiol. 2019 May;25(3):183-188. doi: 10.5152/dir.2019.19125.

28.

Immuno-PET Imaging of the Programmed Cell Death-1 Ligand (PD-L1) Using a Zirconium-89 Labeled Therapeutic Antibody, Avelumab.

Jagoda EM, Vasalatiy O, Basuli F, Opina ACL, Williams MR, Wong K, Lane KC, Adler S, Ton AT, Szajek LP, Xu B, Butcher D, Edmondson EF, Swenson RE, Greiner J, Gulley J, Eary J, Choyke PL.

Mol Imaging. 2019 Jan-Dec;18:1536012119829986. doi: 10.1177/1536012119829986.

29.

mpMRI preoperative staging in men treated with antiandrogen and androgen deprivation therapy before robotic prostatectomy.

Gold SA, VanderWeele DJ, Harmon S, Bloom JB, Karzai F, Hale GR, Marhamati S, Rayn KN, Mehralivand S, Merino MJ, Gulley JL, Bilusic M, Madan RA, Choyke PL, Turkbey B, Dahut W, Pinto PA.

Urol Oncol. 2019 Jun;37(6):352.e25-352.e30. doi: 10.1016/j.urolonc.2019.01.012. Epub 2019 Apr 15.

PMID:
31000430
30.

Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI.

Greer MD, Shih JH, Lay N, Barrett T, Bittencourt L, Borofsky S, Kabakus I, Law YM, Marko J, Shebel H, Merino MJ, Wood BJ, Pinto PA, Summers RM, Choyke PL, Turkbey B.

AJR Am J Roentgenol. 2019 Mar 27:1-8. doi: 10.2214/AJR.18.20536. [Epub ahead of print]

PMID:
30917023
31.

First-in-human phase 0 study of 111In-CHX-A"-DTPA trastuzumab for HER2 tumor imaging.

Kurdziel KA, Mena E, McKinney Y, Wong K, Adler S, Sissung T, Lee J, Lipkowitz S, Lindenberg L, Turkbey B, Kummar S, Milenic DE, Doroshow JH, Figg WD, Merino MJ, Paik CH, Brechbiel MW, Choyke PL.

J Transl Sci. 2019 Apr;5(2). doi: 10.15761/JTS.1000269. Epub 2018 Jul 13.

32.

Deep neural maps for unsupervised visualization of high-grade cancer in prostate biopsies.

Sedghi A, Pesteie M, Javadi G, Azizi S, Yan P, Kwak JT, Xu S, Turkbey B, Choyke P, Pinto P, Wood B, Rohling R, Abolmaesumi P, Mousavi P.

Int J Comput Assist Radiol Surg. 2019 Jun;14(6):1009-1016. doi: 10.1007/s11548-019-01950-0. Epub 2019 Mar 23.

PMID:
30905010
33.

Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2.

Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F, Margolis DJ, Thoeny HC, Verma S, Barentsz J, Weinreb JC.

Eur Urol. 2019 Sep;76(3):340-351. doi: 10.1016/j.eururo.2019.02.033. Epub 2019 Mar 18. Review.

PMID:
30898406
34.

Prostate Imaging Reporting and Data System Version 2 for MRI of Prostate Cancer: Can We Do Better?

Sackett J, Choyke PL, Turkbey B.

AJR Am J Roentgenol. 2019 Mar 19:1-9. doi: 10.2214/AJR.19.21178. [Epub ahead of print]

PMID:
30888865
35.

Prostate cancer detection from multi-institution multiparametric MRIs using deep convolutional neural networks.

Sumathipala Y, Lay N, Turkbey B, Smith C, Choyke PL, Summers RM.

J Med Imaging (Bellingham). 2018 Oct;5(4):044507. doi: 10.1117/1.JMI.5.4.044507. Epub 2018 Dec 15. Erratum in: J Med Imaging (Bellingham). 2019 Jul;6(3):039803.

PMID:
30840728
36.

Novel Imaging in Detection of Metastatic Prostate Cancer.

Smith CP, Laucis A, Harmon S, Mena E, Lindenberg L, Choyke PL, Turkbey B.

Curr Oncol Rep. 2019 Mar 5;21(4):31. doi: 10.1007/s11912-019-0780-8. Review.

PMID:
30834999
37.

Dynamic Imaging of Glucose and Lactate Metabolism by 13C-MRS without Hyperpolarization.

Brender JR, Kishimoto S, Merkle H, Reed G, Hurd RE, Chen AP, Ardenkjaer-Larsen JH, Munasinghe J, Saito K, Seki T, Oshima N, Yamamoto K, Choyke PL, Mitchell J, Krishna MC.

Sci Rep. 2019 Mar 4;9(1):3410. doi: 10.1038/s41598-019-38981-1.

38.

The Distribution Volume of 18F-Albumin as a Potential Biomarker of Antiangiogenic Treatment Efficacy.

Roy J, Kuo F, Basuli F, Williams MR, Wong K, Green MV, Seidel J, Adler SS, Xu B, Choyke PL, Jagoda EM.

Cancer Biother Radiopharm. 2019 May;34(4):238-244. doi: 10.1089/cbr.2018.2656. Epub 2019 Feb 15.

PMID:
30767667
39.

Targeting Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor 2 (HER2) Expressing Bladder Cancer Using Combination Photoimmunotherapy (PIT).

Siddiqui MR, Railkar R, Sanford T, Crooks DR, Eckhaus MA, Haines D, Choyke PL, Kobayashi H, Agarwal PK.

Sci Rep. 2019 Feb 14;9(1):2084. doi: 10.1038/s41598-019-38575-x.

40.

PET imaging in renal cancer.

Lindenberg L, Mena E, Choyke PL, Bouchelouche K.

Curr Opin Oncol. 2019 May;31(3):216-221. doi: 10.1097/CCO.0000000000000518.

PMID:
30747736
41.

A comparison of prostate cancer bone metastases on 18F-Sodium Fluoride and Prostate Specific Membrane Antigen (18F-PSMA) PET/CT: Discordant uptake in the same lesion.

Harmon SA, Mena E, Shih JH, Adler S, McKinney Y, Bergvall E, Mehralivand S, Sowalsky AG, Couvillon A, Madan RA, Gulley JL, Eary J, Mease RC, Pomper MG, Dahut WL, Turkbey B, Lindenberg L, Choyke PL.

Oncotarget. 2018 Dec 28;9(102):37676-37688. doi: 10.18632/oncotarget.26481. eCollection 2018 Dec 28.

42.

Prostate Magnetic Resonance Imaging: Lesion Detection and Local Staging.

Turkbey B, Choyke PL.

Annu Rev Med. 2019 Jan 27;70:451-459. doi: 10.1146/annurev-med-053117-123215.

PMID:
30691375
43.

Host Immunity Following Near-Infrared Photoimmunotherapy Is Enhanced with PD-1 Checkpoint Blockade to Eradicate Established Antigenic Tumors.

Nagaya T, Friedman J, Maruoka Y, Ogata F, Okuyama S, Clavijo PE, Choyke PL, Allen C, Kobayashi H.

Cancer Immunol Res. 2019 Mar;7(3):401-413. doi: 10.1158/2326-6066.CIR-18-0546. Epub 2019 Jan 25.

PMID:
30683733
44.

Focal laser ablation as clinical treatment of prostate cancer: report from a Delphi consensus project.

van Luijtelaar A, Greenwood BM, Ahmed HU, Barqawi AB, Barret E, Bomers JGR, Brausi MA, Choyke PL, Cooperberg MR, Eggener S, Feller JF, Frauscher F, George AK, Hindley RG, Jenniskens SFM, Klotz L, Kovacs G, Lindner U, Loeb S, Margolis DJ, Marks LS, May S, Mcclure TD, Montironi R, Nour SG, Oto A, Polascik TJ, Rastinehad AR, De Reyke TM, Reijnen JS, de la Rosette JJMCH, Sedelaar JPM, Sperling DS, Walser EM, Ward JF, Villers A, Ghai S, Fütterer JJ.

World J Urol. 2019 Oct;37(10):2147-2153. doi: 10.1007/s00345-019-02636-7. Epub 2019 Jan 22.

45.

A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.

Mehralivand S, Shih JH, Harmon S, Smith C, Bloom J, Czarniecki M, Gold S, Hale G, Rayn K, Merino MJ, Wood BJ, Pinto PA, Choyke PL, Turkbey B.

Radiology. 2019 Mar;290(3):709-719. doi: 10.1148/radiol.2018181278. Epub 2019 Jan 22.

PMID:
30667329
46.

Predicting Gleason Group Progression for Men on Prostate Cancer Active Surveillance: Role of a Negative Confirmatory Magnetic Resonance Imaging-Ultrasound Fusion Biopsy.

Bloom JB, Hale GR, Gold SA, Rayn KN, Smith C, Mehralivand S, Czarniecki M, Valera V, Wood BJ, Merino MJ, Choyke PL, Parnes HL, Turkbey B, Pinto PA.

J Urol. 2019 Jan;201(1):84-90. doi: 10.1016/j.juro.2018.07.051.

PMID:
30577395
47.

Intra- and interreader reproducibility of PI-RADSv2: A multireader study.

Smith CP, Harmon SA, Barrett T, Bittencourt LK, Law YM, Shebel H, An JY, Czarniecki M, Mehralivand S, Coskun M, Wood BJ, Pinto PA, Shih JH, Choyke PL, Turkbey B.

J Magn Reson Imaging. 2019 Jun;49(6):1694-1703. doi: 10.1002/jmri.26555. Epub 2018 Dec 21.

PMID:
30575184
48.

Photoinduced Ligand Release from a Silicon Phthalocyanine Dye Conjugated with Monoclonal Antibodies: A Mechanism of Cancer Cell Cytotoxicity after Near-Infrared Photoimmunotherapy.

Sato K, Ando K, Okuyama S, Moriguchi S, Ogura T, Totoki S, Hanaoka H, Nagaya T, Kokawa R, Takakura H, Nishimura M, Hasegawa Y, Choyke PL, Ogawa M, Kobayashi H.

ACS Cent Sci. 2018 Nov 28;4(11):1559-1569. doi: 10.1021/acscentsci.8b00565. Epub 2018 Nov 6.

49.

Bone marrow cell homing to sites of acute tibial fracture: 89Zr-oxine cell labeling with positron emission tomographic imaging in a mouse model.

Asiedu KO, Ferdousi M, Ton PT, Adler SS, Choyke PL, Sato N.

EJNMMI Res. 2018 Dec 13;8(1):109. doi: 10.1186/s13550-018-0463-8.

50.

Pitfalls on sample preparation for ex vivo imaging of resected cancer tissue using enzyme-activatable fluorescent probes.

Mochida A, Ogata F, Maruoka Y, Nagaya T, Okada R, Inagaki F, Fujimura D, Choyke PL, Kobayashi H.

Oncotarget. 2018 Nov 13;9(89):36039-36047. doi: 10.18632/oncotarget.26320. eCollection 2018 Nov 13.

Supplemental Content

Loading ...
Support Center